Home

Jeffrey Sevigny

CIK 1778483 · Chief Medical Officer · last filed 2026-02-04

Jeffrey Sevigny is a Chief Medical Officer who has filed 6 SEC Form 4 insider transactions across 3 companies since 2020. The most recent filing, for RAPP, was dated Feb 4, 2026.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

3

Total Filings

6

Lifetime Open-Market Net

$0

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
RAPP Chief Medical Officer — $38.40 — $0 2 2026-02-04
ABOS Director — $2.37 — $0 2 2022-06-17
Prevail Therapeutics Inc. (PRVL) Delisted Chief Medical Officer — — — $0 1 2020-03-11

Recent Filings

6 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2026-02-04 RAPP Grant (A) — $0 EDGAR
2025-04-03 RAPP Grant (A) — $0 EDGAR
2022-06-17 ABOS Grant (A) — $0 EDGAR
2021-07-02 ABOS Grant (A) — $0 EDGAR
2021-01-26 — Disp (D) — $0
2020-03-11 Prevail Therapeutics Inc. (PRVL) Delisted Grant (A) — $0 EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.